Plaque progression and regression in atherothrombosis

被引:47
作者
Ibanez, B. [1 ]
Vilahur, G. [1 ]
Badimon, J. J. [1 ]
机构
[1] Mt Sinai Sch Med, Zena & Michael A Wiener Cardiovasc Inst, New York, NY 10029 USA
关键词
D O I
10.1111/j.1538-7836.2007.02483.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Atherosclerotic disease is a pathological process characterized by the deposition of lipid and other blood-borne material within the arterial wall. The deposition of these materials and the subsequent thickening of the wall may significantly compromise the vessel lumen. Atherosclerosis is a diffuse disease with focal clinical manifestations that are the consequence of thrombotic complications on disrupted atherosclerotic lesions. Until recently, atherosclerosis development was envisaged as an incessant progressing process; however, new evidence has shown that atherosclerotic plaque homeostasis is not necessarily a constantly progressing process. There are many data showing that atherosclerotic plaque formation can be slowed, stopped or even reversed. Comprehension of the underlying mechanisms involved in the homeostasis of atherosclerotic plaque (progression/regression) should allow the development of interventions enhancing the regression pathway. Novel imaging technology has allowed the accurate evaluation of plaque progression, vital in the assessment of the efficacy of interventions. In this review we discuss the processes involved in the formation and progression of atherosclerotic lesions, the triggers for plaque disruption, as well as new therapies. We also deal with the potential pathways of plaque regression, as well as tools for accurate serial atherosclerotic quantification.
引用
收藏
页码:292 / 299
页数:8
相关论文
共 30 条
[21]   PRAVASTATIN LIMITATION OF ATHEROSCLEROSIS IN THE CORONARY-ARTERIES (PLAC-I) - REDUCTION IN ATHEROSCLEROSIS PROGRESSION AND CLINICAL EVENTS [J].
PITT, B ;
MANCINI, GBJ ;
ELLIS, SG ;
ROSMAN, HS ;
PARK, JS ;
MCGOVERN, ME .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 26 (05) :1133-1139
[22]   Aggressive versus moderate lipid-lowering therapy in hypercholesterolemic postmenopausal women - beyond endorsed lipid lowering with EBT scanning (BELLES) [J].
Raggi, P ;
Davidson, M ;
Callister, TQ ;
Welty, FK ;
Bachmann, GA ;
Hecht, H ;
Rumberger, JA .
CIRCULATION, 2005, 112 (04) :563-571
[23]  
Sambola A, 2004, REV ESP CARDIOL, V57, P596
[24]   The failure of torcetrapib - Was it the molecule or the mechanism? [J].
Tall, Alan R. ;
Yvan-Charvet, Laurent ;
Wang, Nan .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (02) :257-260
[25]   The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3 [J].
Taylor, Allen J. ;
Lee, Hyun J. ;
Sullenberger, Lance E. .
CURRENT MEDICAL RESEARCH AND OPINION, 2006, 22 (11) :2243-2250
[26]   BAY 59-7939:: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement.: A phase II dose-ranging study [J].
Turpie, AGG ;
Fisher, WD ;
Bauer, KA ;
Kwong, LM ;
Irwin, MW ;
Kälebo, P ;
Misselwitz, F ;
Gent, M .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (11) :2479-2486
[27]   The evolving role of statins in the management of atherosclerosis [J].
Vaughan, CJ ;
Gotto, AM ;
Basson, CT .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2000, 35 (01) :1-10
[28]  
VILAHUR G, 2006, INT J ATHEROSCLER, V1, P143
[29]   Atherosclerotic plaque progression and vulnerability to rupture - Angiogenesis as a source of intraplaque hemorrhage [J].
Virmani, R ;
Kolodgie, FD ;
Burke, AP ;
Finn, AV ;
Gold, HK ;
Tulenko, TN ;
Wrenn, SP ;
Narula, J .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (10) :2054-2061
[30]   Does shear stress modulate both plaque progression and regression in the thoracic aorta? [J].
Wentzel, JJ ;
Corti, R ;
Fayad, ZA ;
Wisdom, P ;
Macaluso, F ;
Winkelman, MO ;
Fuster, V ;
Badimon, JJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (06) :846-854